JPH0413759A - Aromatic polycarbonate resin composition and medical goods made thereof - Google Patents
Aromatic polycarbonate resin composition and medical goods made thereofInfo
- Publication number
- JPH0413759A JPH0413759A JP2116474A JP11647490A JPH0413759A JP H0413759 A JPH0413759 A JP H0413759A JP 2116474 A JP2116474 A JP 2116474A JP 11647490 A JP11647490 A JP 11647490A JP H0413759 A JPH0413759 A JP H0413759A
- Authority
- JP
- Japan
- Prior art keywords
- aromatic polycarbonate
- polycarbonate resin
- resin composition
- bis
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004431 polycarbonate resin Substances 0.000 title claims abstract description 29
- 229920005668 polycarbonate resin Polymers 0.000 title claims abstract description 28
- 125000003118 aryl group Chemical group 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 14
- 125000005843 halogen group Chemical group 0.000 claims abstract description 11
- 229920000642 polymer Polymers 0.000 claims abstract description 11
- 229920001451 polypropylene glycol Polymers 0.000 claims abstract description 9
- VPWNQTHUCYMVMZ-UHFFFAOYSA-N 4,4'-sulfonyldiphenol Chemical class C1=CC(O)=CC=C1S(=O)(=O)C1=CC=C(O)C=C1 VPWNQTHUCYMVMZ-UHFFFAOYSA-N 0.000 claims description 12
- 230000005865 ionizing radiation Effects 0.000 abstract description 13
- -1 halogenated bisphenol compound Chemical class 0.000 abstract description 11
- 150000001875 compounds Chemical class 0.000 abstract description 7
- 239000011342 resin composition Substances 0.000 abstract description 6
- 230000001954 sterilising effect Effects 0.000 abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 6
- 239000000463 material Substances 0.000 abstract description 3
- 230000000704 physical effect Effects 0.000 abstract description 3
- 125000000217 alkyl group Chemical group 0.000 abstract description 2
- 238000002845 discoloration Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 description 12
- 229920005989 resin Polymers 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 8
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 7
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- PXKLMJQFEQBVLD-UHFFFAOYSA-N bisphenol F Chemical compound C1=CC(O)=CC=C1CC1=CC=C(O)C=C1 PXKLMJQFEQBVLD-UHFFFAOYSA-N 0.000 description 4
- 238000001746 injection moulding Methods 0.000 description 4
- 239000001294 propane Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- VEORPZCZECFIRK-UHFFFAOYSA-N 3,3',5,5'-tetrabromobisphenol A Chemical compound C=1C(Br)=C(O)C(Br)=CC=1C(C)(C)C1=CC(Br)=C(O)C(Br)=C1 VEORPZCZECFIRK-UHFFFAOYSA-N 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 150000003462 sulfoxides Chemical class 0.000 description 3
- 238000004383 yellowing Methods 0.000 description 3
- KTMNDTPAJZKQPF-UHFFFAOYSA-N 2-tert-butyl-4-[1-(3-tert-butyl-4-hydroxyphenyl)propyl]phenol Chemical compound C=1C=C(O)C(C(C)(C)C)=CC=1C(CC)C1=CC=C(O)C(C(C)(C)C)=C1 KTMNDTPAJZKQPF-UHFFFAOYSA-N 0.000 description 2
- CKNCVRMXCLUOJI-UHFFFAOYSA-N 3,3'-dibromobisphenol A Chemical compound C=1C=C(O)C(Br)=CC=1C(C)(C)C1=CC=C(O)C(Br)=C1 CKNCVRMXCLUOJI-UHFFFAOYSA-N 0.000 description 2
- VWGKEVWFBOUAND-UHFFFAOYSA-N 4,4'-thiodiphenol Chemical compound C1=CC(O)=CC=C1SC1=CC=C(O)C=C1 VWGKEVWFBOUAND-UHFFFAOYSA-N 0.000 description 2
- RQCACQIALULDSK-UHFFFAOYSA-N 4-(4-hydroxyphenyl)sulfinylphenol Chemical compound C1=CC(O)=CC=C1S(=O)C1=CC=C(O)C=C1 RQCACQIALULDSK-UHFFFAOYSA-N 0.000 description 2
- RSSGMIIGVQRGDS-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)-phenylmethyl]phenol Chemical compound C1=CC(O)=CC=C1C(C=1C=CC(O)=CC=1)C1=CC=CC=C1 RSSGMIIGVQRGDS-UHFFFAOYSA-N 0.000 description 2
- QHJPJZROUNGTRJ-UHFFFAOYSA-N 4-[2-(4-hydroxyphenyl)octan-2-yl]phenol Chemical compound C=1C=C(O)C=CC=1C(C)(CCCCCC)C1=CC=C(O)C=C1 QHJPJZROUNGTRJ-UHFFFAOYSA-N 0.000 description 2
- HTVITOHKHWFJKO-UHFFFAOYSA-N Bisphenol B Chemical compound C=1C=C(O)C=CC=1C(C)(CC)C1=CC=C(O)C=C1 HTVITOHKHWFJKO-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- KYPYTERUKNKOLP-UHFFFAOYSA-N Tetrachlorobisphenol A Chemical compound C=1C(Cl)=C(O)C(Cl)=CC=1C(C)(C)C1=CC(Cl)=C(O)C(Cl)=C1 KYPYTERUKNKOLP-UHFFFAOYSA-N 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 150000002896 organic halogen compounds Chemical class 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 238000009864 tensile test Methods 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- HCNHNBLSNVSJTJ-UHFFFAOYSA-N 1,1-Bis(4-hydroxyphenyl)ethane Chemical compound C=1C=C(O)C=CC=1C(C)C1=CC=C(O)C=C1 HCNHNBLSNVSJTJ-UHFFFAOYSA-N 0.000 description 1
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 description 1
- RVHUMFJSCJBNGS-UHFFFAOYSA-N 2-[2,6-dibromo-4-[2-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]propan-2-yl]phenoxy]ethanol Chemical compound C=1C(Br)=C(OCCO)C(Br)=CC=1C(C)(C)C1=CC(Br)=C(OCCO)C(Br)=C1 RVHUMFJSCJBNGS-UHFFFAOYSA-N 0.000 description 1
- YMTYZTXUZLQUSF-UHFFFAOYSA-N 3,3'-Dimethylbisphenol A Chemical compound C1=C(O)C(C)=CC(C(C)(C)C=2C=C(C)C(O)=CC=2)=C1 YMTYZTXUZLQUSF-UHFFFAOYSA-N 0.000 description 1
- NZGQHKSLKRFZFL-UHFFFAOYSA-N 4-(4-hydroxyphenoxy)phenol Chemical compound C1=CC(O)=CC=C1OC1=CC=C(O)C=C1 NZGQHKSLKRFZFL-UHFFFAOYSA-N 0.000 description 1
- OVVCSFQRAXVPGT-UHFFFAOYSA-N 4-[1-(4-hydroxyphenyl)cyclopentyl]phenol Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)CCCC1 OVVCSFQRAXVPGT-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- VCCBEIPGXKNHFW-UHFFFAOYSA-N biphenyl-4,4'-diol Chemical group C1=CC(O)=CC=C1C1=CC=C(O)C=C1 VCCBEIPGXKNHFW-UHFFFAOYSA-N 0.000 description 1
- 229920000402 bisphenol A polycarbonate polymer Polymers 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000001924 cycloalkanes Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 150000001987 diarylethers Chemical class 0.000 description 1
- ROORDVPLFPIABK-UHFFFAOYSA-N diphenyl carbonate Chemical compound C=1C=CC=CC=1OC(=O)OC1=CC=CC=C1 ROORDVPLFPIABK-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 238000010101 extrusion blow moulding Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001230 polyarylate Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 238000004394 yellowing prevention Methods 0.000 description 1
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
【発明の詳細な説明】
［産業上の利用分野］
ポリカーボネート樹脂は、機械的・熱的特性に優れ、広
範な用途に使用されている。また、透明性・衛生性にも
優れるために、医療用部品や飲食物と接触する容器等に
も使われている。本発明は、こうした用途に用いられる
際に殺菌のための電離放射線の照射処理を行っても、色
調や物性劣化が少なく、しかも流動性が良好な芳香族ポ
リカーボネート樹脂組成物、及びかかる樹脂組成物を使
用した芳香族ポリカーボネート樹脂製医療用部品を提供
するものである。[Detailed Description of the Invention] [Industrial Application Field] Polycarbonate resin has excellent mechanical and thermal properties and is used in a wide range of applications. Additionally, because of its excellent transparency and hygiene, it is used in medical parts and containers that come into contact with food and drink. The present invention provides an aromatic polycarbonate resin composition that exhibits little deterioration in color tone and physical properties and has good fluidity even when irradiated with ionizing radiation for sterilization when used in such applications, and such a resin composition. The present invention provides medical parts made of aromatic polycarbonate resin.
［従来の技術１
芳香族ポリカーボネート樹脂は、透明性、衛生性に優れ
、強靭で耐熱性にも秀でているため、注射器、外科用具
、静脈注射器、手術用器具などを収容、包装する容器状
包装具や、人口肺、人口腎臓、麻酔吸収装置、静脈用コ
ネクター及びこれらの付属品、血液遠心分離装置等の医
療用装置、外科用具、手術用具など、各種の医療用の部
品に使用されている。これらの医療用部品は、通常、完
全滅菌が行われる。具体的には、エチレンオキサイドに
よる接触処理、オートクレーブ中での加熱処理、または
、ガンマ線や電子線等の電離放射線の放射が挙げられる
。[Conventional technology 1] Aromatic polycarbonate resin has excellent transparency, hygiene, toughness, and heat resistance, so it is used in the form of containers for storing and packaging syringes, surgical tools, intravenous syringes, surgical instruments, etc. It is used in various medical parts such as packaging materials, artificial lungs, artificial kidneys, anesthesia absorption devices, intravenous connectors and their accessories, medical devices such as blood centrifugation devices, surgical tools, and surgical tools. There is. These medical parts are usually completely sterilized. Specifically, contact treatment with ethylene oxide, heat treatment in an autoclave, or radiation of ionizing radiation such as gamma rays or electron beams may be mentioned.
このうち、エチレンオキサイドを使用するのは、エチレ
ンオキサイド自体の毒性、不安定性、及び、廃棄処理に
関連する環境問題等があり、好ましくない。従って、オ
ートクレーブを使用する場合には、高温処理の際に樹脂
の劣化を招くことがあること、エネルギーコストが高い
こと、及び、処理後の部品に湿気が残るために使用前に
乾燥する必要があるという欠点を有する。Among these, it is not preferable to use ethylene oxide because of the toxicity and instability of ethylene oxide itself, as well as environmental problems associated with disposal. Therefore, when using an autoclave, the resin may deteriorate during high-temperature processing, the energy cost is high, and the parts must be dried before use because moisture remains in the parts after processing. It has the disadvantage of being.
従って、低温で処理でき、しかも比較的に安価である電
離放射線による殺菌処理が、これらの方法に代わって使
用されている。Therefore, sterilization treatments using ionizing radiation, which can be processed at low temperatures and are relatively inexpensive, are being used instead of these methods.
さ発明が解決しようとする課題］
は、電離放射線を照射されると、本来は光学的に透明な
樹脂が、黄色く変色する。このため、樹脂中に青果着色
剤を混入して黄色を相殺する方法や、硼素系化合物を配
合したり（特開昭６１Ｈ２１５６５１）、ポリエーテル
ポリオール又はそのアルキルエーテルを配合したり（特
開昭６２−１３５５５６ ）する方法等が提案されてい
る。Problems to be Solved by the Invention] When irradiated with ionizing radiation, the originally optically transparent resin turns yellow. For this reason, there are methods of mixing fruit and vegetable colorants into the resin to offset the yellow color, blending boron-based compounds (Japanese Patent Laid-Open No. 61 H215651), blending polyether polyols or their alkyl ethers (Japanese Patent Laid-Open No. 62 -135556) methods have been proposed.
これらの方法を利用して得られた芳香族ポリカーボネー
ト樹脂は、しかしながら、黄変を防止する効果が充分で
ないか、または効果を発現するに充分な量の黄変防止剤
を配合せしむると樹脂自体の強度を著しく損ない、強度
的に使用に耐えないという欠点を有する。However, the aromatic polycarbonate resins obtained using these methods do not have a sufficient yellowing prevention effect, or the resin deteriorates when a sufficient amount of yellowing inhibitor is added to exhibit the effect. It has the disadvantage that it significantly impairs its own strength and cannot withstand use in terms of strength.
また、医療用部品は小型・軽量で扱い易いことが望まし
く、複雑で薄肉の成形品を製造出来ることが要求され、
本来は流動性が悪く成形性に劣る芳香族ポリカーボネー
ト樹脂では成形加工面で制限を受けることがある。In addition, it is desirable for medical parts to be small, lightweight, and easy to handle, and it is also necessary to be able to manufacture complex and thin-walled molded products.
Aromatic polycarbonate resins, which originally have poor fluidity and poor moldability, may be subject to limitations in terms of molding process.
したがって、電離放射線による殺菌処理に際して黄変が
極めて少なく（耐電離放射線性が良好）、なおかつ充分
な強度と強靭性を保持しながら、流動性が極めて優れた
芳香族ポリカーボネート樹脂組成物、並びにそれよりな
る医療用部品は未だ得られていないのが実情であった。Therefore, an aromatic polycarbonate resin composition that exhibits extremely little yellowing (good resistance to ionizing radiation) during sterilization treatment with ionizing radiation, and has extremely excellent fluidity while maintaining sufficient strength and toughness, The reality is that medical parts have not yet been obtained.
［課題を解決するための手段］
本発明者らは、上記問題点に鑑み鋭意検利した結果、特
定の有機ハロゲン化合物、もしくはこれに更にポリプロ
ピレングリコールを配合した芳香族ポリカーボネート樹
脂組成物が、電離放射線の照射を受けても色調の変化が
少なく、しかも、物理的特性を保持しながら流動性が著
しく改良され、薄肉で複雑な成形品が得られることを見
出し、本発明に到達した。[Means for Solving the Problems] As a result of intensive investigation in view of the above-mentioned problems, the present inventors have found that a specific organic halogen compound or an aromatic polycarbonate resin composition in which polypropylene glycol is further blended with the organic halogen compound is ionizable. The present invention was achieved by discovering that even when irradiated with radiation, there is little change in color tone, the fluidity is significantly improved while maintaining physical properties, and a thin-walled and complex molded product can be obtained.
すなわち、本発明の要旨は、
（１）ハロゲン化ビスフェノール類のアルキレンオキサ
イド付加物及びｌ又はその多量体を、ハロゲン原子とし
て０．１〜１０重量％含有する芳香族ポリカーボネート
樹脂組成物、
（２）ハロゲン化ビスフェノール類のアルキレンオキサ
イド付加物及びｌ又はその多量体をハロゲン原子として
０．１〜１０重量％、及びポリプロピレングリコールを
０．１〜５重量％含有する芳香族ポリカーボネート樹脂
組成物、及びこれらの芳香族ポリカーボネート樹脂組成
物よりなる医療用部品、
に存する。That is, the gist of the present invention is as follows: (1) an aromatic polycarbonate resin composition containing 0.1 to 10% by weight of an alkylene oxide adduct of a halogenated bisphenol and l or a polymer thereof as a halogen atom; (2) An aromatic polycarbonate resin composition containing 0.1 to 10% by weight of an alkylene oxide adduct of halogenated bisphenols and l or its polymer as a halogen atom, and 0.1 to 5% by weight of polypropylene glycol, and these A medical component comprising an aromatic polycarbonate resin composition.
以下、本発明を具体的に説明する。The present invention will be explained in detail below.
本発明において使用される芳香族ポリカーボネート樹脂
とは、種々のジヒドロキシジアリール化合物とホスゲン
とを反応させるホスゲン法、またはジヒドロキシジアリ
ール化合物とジフェニルカーボネートなどの炭酸エステ
ルとを反応させるエステル交換法によって得られる重合
体であり、代表的なものとしては、２，２−ビス（４−
ヒドロキシフェニル）プロパン（ビスフェノールＡ）か
ら製造すれたポリカーボネート樹脂が挙げられる。The aromatic polycarbonate resin used in the present invention is a polymer obtained by a phosgene method in which various dihydroxydiaryl compounds are reacted with phosgene, or a transesterification method in which a dihydroxydiaryl compound is reacted with a carbonate ester such as diphenyl carbonate. A typical example is 2,2-bis(4-
Examples include polycarbonate resins made from hydroxyphenyl)propane (bisphenol A).
上記ジヒドロキシジアリール化合物としては、ビスフェ
ノールＡの他に、ビス（４−ヒドロキシフェニル）メタ
ン、１，１−ビス（４−ヒドロキシフェニル）エタン、
２，２−ビス（４−ヒドロキシフェニル）ブタン、２，
２−ビス（４−ヒドロキシフェニル）オクタン、ビス（
４−ヒドロキシフェニル）フェニルメタン、２，２−ビ
ス（４−ヒドロキシ−３−メチルフエニル）プロパン、
１，１−ビス（４−ヒドロキシ−３−第三ブチルフェニ
ル）プロパン、２，２−ビス（４−ヒドロキシ−３−ブ
ロモフェニル）プロパン、２．２−ヒス（４−ヒドロキ
シ−３，５−ジブロモフェニル）プロパン、２．２−ビ
ス（４−ヒドロキシ−３，５−ジクロロフェニル）プロ
パンのようなビス（ヒドロキシアリール）アルカン類、
１，１−ビス（４−ヒドロキシフェニル）シクロペンタ
ン、１．ｌ−ビス（４−ヒドロキシフェニル）シクロヘ
キサンのようなビス（ヒドロキシアリール）シクロアル
カン類、４，４′−ジヒドロキシジフェニルエーテル、
４．４’−ジヒドロキシ−３，３′−ジメチルジフェニ
ルエーテル、のようなジヒドロキシジアリールエーテル
類、４，４′−ジヒドロキシジフェニルスルフィド、４
．４’−ジヒドロキシ−３，３’−ジメチルジフェニル
スルフィドのようなジヒドロキシジアリールスルフィド
類、４，４′−ジヒドロキシジフェニルスルホキシド、
４，４′−ジヒドロキシ−３゜３′−ジメチルジフェニ
ルスルホキシドのようなジヒドロキシジアリールスルホ
キシド類、４，４′−ジヒドロキシジフェニルスルホン
、４，４′−ジヒドロキシ−３，３′−ジメチルジフェ
ニルスルホンのようなジヒドロキシジアリールスルホン
類等が挙げられる。In addition to bisphenol A, the dihydroxydiaryl compounds include bis(4-hydroxyphenyl)methane, 1,1-bis(4-hydroxyphenyl)ethane,
2,2-bis(4-hydroxyphenyl)butane, 2,
2-bis(4-hydroxyphenyl)octane, bis(
4-hydroxyphenyl)phenylmethane, 2,2-bis(4-hydroxy-3-methylphenyl)propane,
1,1-bis(4-hydroxy-3-tert-butylphenyl)propane, 2,2-bis(4-hydroxy-3-bromophenyl)propane, 2,2-his(4-hydroxy-3,5- bis(hydroxyaryl)alkanes such as dibromophenyl)propane, 2,2-bis(4-hydroxy-3,5-dichlorophenyl)propane,
1,1-bis(4-hydroxyphenyl)cyclopentane, 1. bis(hydroxyaryl)cycloalkanes such as l-bis(4-hydroxyphenyl)cyclohexane, 4,4'-dihydroxydiphenyl ether,
4. Dihydroxydiarylethers such as 4'-dihydroxy-3,3'-dimethyldiphenyl ether, 4,4'-dihydroxydiphenyl sulfide, 4
．． dihydroxydiaryl sulfides such as 4'-dihydroxy-3,3'-dimethyldiphenyl sulfide, 4,4'-dihydroxydiphenyl sulfoxide,
Dihydroxydiaryl sulfoxides such as 4,4'-dihydroxy-3゜3'-dimethyldiphenyl sulfoxide, 4,4'-dihydroxydiphenyl sulfone, 4,4'-dihydroxy-3,3'-dimethyldiphenyl sulfone, etc. Examples include dihydroxydiarylsulfones.
これらは単独または２種以上混合して使用されるが、こ
れらに加えて、ピペラジン、ジピペリジルハイドロキノ
ン、レゾルシン、４，４′−ジヒドロキシジフェニル等
を併用してもよい。These may be used alone or in combination of two or more, but in addition to these, piperazine, dipiperidyl hydroquinone, resorcinol, 4,4'-dihydroxydiphenyl, etc. may be used in combination.
本発明で使用される芳香族ポリカーボネート樹脂は、好
ましくは粘度平均分子量１０，０００〜４０，０００、
更に好ましくは１５，０００〜３０，０００、特に好ま
しくは１８，０００〜２５，０００のものである。The aromatic polycarbonate resin used in the present invention preferably has a viscosity average molecular weight of 10,000 to 40,000,
More preferably, it is 15,000 to 30,000, particularly preferably 18,000 to 25,000.
また本発明において使用されるハロゲン化ビスフェノー
ル類のアルキレンオキサイド付加物及びｌ又はその多量
体としては、例えば下記（イ）、（ロ）で示すような一
般式（Ｉ）又は（ＩＩ ）で表されるものが挙げられる
。In addition, the alkylene oxide adducts of halogenated bisphenols and l or polymers thereof used in the present invention are, for example, those represented by general formulas (I) or (II) as shown in (a) and (b) below. There are many things that can be mentioned.
［式（Ｉ）中、ｉ、 ｊ：１以上の整数。ｍ：１〜５の
整数。[In formula (I), i, j: an integer of 1 or more. m: an integer from 1 to 5.
Ｒｏ：炭素数２〜４のアルキレン基、
Ｒ１、Ｒ４：炭素数１〜５のアルキル基、又は −ＣＨ
２−ＣＨ−ＣＨ２０Ｈ１
Ｈ
Ｒ２、Ｒ３：Ｈ又は＋ＣＨ２ヤＣＨ３（ｙ ＝ ０〜５
）ＸＩ−Ｌ ：Ｈ，＋ＣＨｚｉＣＨｓ （ｚ ＝ Ｏ〜
５）又はハロゲン原子。Ro: alkylene group having 2 to 4 carbon atoms, R1, R4: alkyl group having 1 to 5 carbon atoms, or -CH
2-CH-CH20H1 H R2, R3: H or +CH2ya CH3 (y = 0-5
)XI-L :H, +CHziCHs (z = O~
5) or a halogen atom.
（ただし、Ｘ１〜ｘ４のうち少くとも１つはハロゲン原
子。月
上記式ＣＩ）において、班、Ｒ３は同一であっても異な
っていてもよい。Ｘ１〜ｘ４はそのうちの少なくとも一
つがハロゲン原子（Ｆ、ＣＩ、Ｂｒ、Ｉ）であり、これ
らは互いに同一の基であっても異なっていても良い。更
に、ｉ及びｊは好ましくは１〜３の整数、ｍは好ましく
は１である。また、＆は、エチレン基の場合（ハロゲン
化ビスフェノール類のエチレンオキサイド付加物又はそ
の多量体）が最も好ましい。(However, at least one of X1 to x4 is a halogen atom. In the above formula CI), the groups and R3 may be the same or different. At least one of X1 to x4 is a halogen atom (F, CI, Br, I), and these may be the same group or different from each other. Furthermore, i and j are preferably integers of 1 to 3, and m is preferably 1. Further, & is most preferably an ethylene group (an ethylene oxide adduct of halogenated bisphenols or a polymer thereof).
上記式（Ｉ）において、ｍ＝１の場合はハロゲン化フェ
ノール類のアルキレンオキサイド付加物、ｍ＝２以上の
場合はその多量体に相当するが、これらは各々単独で、
また２種以上混合して使用することができる。In the above formula (I), when m = 1, it corresponds to an alkylene oxide adduct of a halogenated phenol, and when m = 2 or more, it corresponds to its multimer, but each of these corresponds to
Moreover, two or more types can be mixed and used.
［式（ＩＩ ）中、へ、Ｒ１〜Ｒ４、Ｘ１〜ｘ４、ｉ、
ｊ：式（１）と同様、ｎ：ｌ〜４の整数。ｉ′、ｊ′：
１以上の整数。[In formula (II), to, R1 to R4, X1 to x4, i,
j: As in formula (1), n: an integer from 1 to 4. i', j':
An integer greater than or equal to 1.
Ｒ５＝炭素数１〜１０のアルキレン基、−０−Ｘ５〜ｘ
８：ｘ□〜Ｘ４と同様。R5=alkylene group having 1 to 10 carbon atoms, -0-X5 to x
8: Same as x□~X4.
馬、Ｒ７：Ｒ２、Ｒ３と同様。］
上記式（Ｉ）において、Ｒ２とＲ３、狗とＲ７は互いに
同一であっても異なっていてもよい。Ｘ１〜Ｘ４又はＸ
５〜Ｘ８は各々そのうちの少なくとも一つがノ１０ゲン
原子（Ｆ、Ｃ１、Ｂｒ、Ｉ）であり、これらは互いに同
一の基であっても異なっていても良い。更に、ｉ′及び
ｊ′は好ましくは１〜３の整数、ｎは好ましくは１であ
る。また、氏は、エチレン基の場合が最も好ましい。上
記式（ＩＩ）において、ｎ；１の場合及びｎ＝２以上の
場合について、各々単独で、または２種以上混合して使
用することができる。Horse, R7: Same as R2 and R3. ] In the above formula (I), R2 and R3, dog and R7 may be the same or different from each other. X1-X4 or X
At least one of each of 5 to X8 is a nitrogen atom (F, C1, Br, I), and these may be the same group or different from each other. Furthermore, i' and j' are preferably integers of 1 to 3, and n is preferably 1. Moreover, the case where Mr. is an ethylene group is most preferable. In the above formula (II), when n is 1 and when n is 2 or more, each can be used alone or in a mixture of two or more kinds.
ハロゲン化ビスフェノール類の具体的な例としては、ビ
スフェノール類として、２．２−（４−ヒドロキシフェ
ニル）プロパン（ビスフェノールＡ）、ビス（４−ヒド
ロキシフェニル）メタン、１，１−ビス（４−ヒドロキ
シフェニル）エタン、２，２−ビス（４−ヒドロキシフ
ェニル）ブタン、２，２−ビス（４−ヒドロキシフェニ
ル）オクタン、ビス（４−ヒドロキシフェニル）フェニ
ルメタン、２，２−ビス（４−ヒドロキシ−３−メチル
フェニル）プロパン、１，１−ビス（４−ヒドロキシ−
３−第３ブチルフエニル）プロパン、２，２−ビス（４
−ヒドロキシ−３−ブロモフェニル）プロパン、２，２
−ビス（４−ヒドロキシ−３，５ジブロモフエニル）プ
ロパン、２，２−ビス（４−ヒドロキシ−３，５ジクロ
ロフエニル）プロパンのようなビス（ヒドロキシアリー
ル）アルカン類、４，４−ジヒドロキシジフェニルエー
テル、４．４−ジヒドロキシ−３，３′ジメチルジフエ
ニルエーテル、のようなジヒドロキシジアリールエーテ
ル類、４，４′−ジヒドロキシジフェニルスルフィド、
４，４′−ジヒドロキシ−３，３′−ジメチルジフェニ
ルスルフィドのようなジヒドロキシジアリールスルフィ
ド類、４，４′−ジヒドロキシジフェニルスルホキシド
、４，４′−ジヒドロキシ−３，３”−ジメチルジフェ
ニルスルホキシドのようなジヒドロキシジアリールスル
ホキシド類、４，４′−ジヒドロキシジフェニルスルホ
ン、４，４２−ジヒドロキシ−３，３′−ジメチルジフ
ェニルスルホンのようなジヒドロキシジアリールスルホ
ン類等
これらのハロゲン化ビスフェノール類のアルキレンオキ
サイド付加物及び／又はその多量体は、芳香族ポリカー
ボネート樹脂組成物全体に対し、ハロゲン原子としての
含有量が０．１〜１０重量％、好ましくは０．２〜５重
量％となるよう配合される。ハロゲン原子の含有量が０
．１重量％より少ないと、耐電離放射線性の改良効果が
少なく、１０重量％より多くなると、組成物の機械的特
性が著しく低下する。また、該付加物及びｌ又はその多
量体は、その分子量をＡとし、芳香族ポリカーボネート
樹脂に対する配合量をＢ（重量％）として、ＡとＢとの
積が
ＡＸＢ≦３００００
であることが好ましい。ＡとＢとの積が３００００を越
えると、得られる樹脂組成物の透明性が損なわれる。ま
た、該付加物及びｌ又はその多量体の芳香族ポリカーボ
ネート樹脂に対する配合量は、好ましくは１重量％以上
、更に好ましくは１〜１０重量％である。この量が少な
すぎると、流動性が低下するので好ましくない。Specific examples of halogenated bisphenols include 2,2-(4-hydroxyphenyl)propane (bisphenol A), bis(4-hydroxyphenyl)methane, and 1,1-bis(4-hydroxyphenyl). phenyl)ethane, 2,2-bis(4-hydroxyphenyl)butane, 2,2-bis(4-hydroxyphenyl)octane, bis(4-hydroxyphenyl)phenylmethane, 2,2-bis(4-hydroxyphenyl) 3-methylphenyl)propane, 1,1-bis(4-hydroxy-
3-tert-butylphenyl)propane, 2,2-bis(4
-hydroxy-3-bromophenyl)propane, 2,2
-bis(hydroxyaryl)alkanes such as bis(4-hydroxy-3,5 dibromophenyl)propane, 2,2-bis(4-hydroxy-3,5 dichlorophenyl)propane, 4,4-dihydroxy Dihydroxy diaryl ethers such as diphenyl ether, 4,4-dihydroxy-3,3' dimethyl diphenyl ether, 4,4'-dihydroxy diphenyl sulfide,
Dihydroxydiaryl sulfides such as 4,4'-dihydroxy-3,3'-dimethyldiphenyl sulfide, 4,4'-dihydroxydiphenyl sulfoxide, 4,4'-dihydroxy-3,3''-dimethyldiphenyl sulfoxide, etc. Dihydroxydiarylsulfoxides, dihydroxydiarylsulfones such as 4,4'-dihydroxydiphenylsulfone, 4,42-dihydroxy-3,3'-dimethyldiphenylsulfone, alkylene oxide adducts of these halogenated bisphenols and/or The polymer is blended so that the content as halogen atoms is 0.1 to 10% by weight, preferably 0.2 to 5% by weight, based on the entire aromatic polycarbonate resin composition.Containment of halogen atoms amount is 0
．． When it is less than 1% by weight, the effect of improving the ionizing radiation resistance is small, and when it is more than 10% by weight, the mechanical properties of the composition are significantly reduced. Furthermore, it is preferable that the product of A and B is AXB≦30,000, where the molecular weight of the adduct and l or its multimer is A, and the amount blended with the aromatic polycarbonate resin is B (% by weight). If the product of A and B exceeds 30,000, the transparency of the resulting resin composition will be impaired. Further, the amount of the adduct and l or its polymer added to the aromatic polycarbonate resin is preferably 1% by weight or more, more preferably 1 to 10% by weight. If this amount is too small, fluidity will decrease, which is not preferable.
また、本発明において使用されるポリプロピレングリコ
ールは、分子量が５ｏｏｏ以下であることが望ましい。Further, it is desirable that the polypropylene glycol used in the present invention has a molecular weight of 500 or less.
分子量が８０００を越えると、得られる樹脂組成物の透
明性が損なわれる。また、ポリプロピレングリコールの
末端水酸基は、脂肪酸でエステル化したり、グリシジル
化することによって、溶融成形加工時の熱安定性の向上
を図ることが出来る。If the molecular weight exceeds 8,000, the transparency of the resulting resin composition will be impaired. Further, the terminal hydroxyl group of polypropylene glycol can be esterified with a fatty acid or glycidylated to improve thermal stability during melt molding processing.
こうしたポリプロピレングリコールの配合量は、芳香族
ポリカーボネート樹脂組成物全体に対して０．０５〜５
重量％、好ましくは、０．５〜２重量％である。０．０
５重量％未満では、耐電離放射線性の効果が不十分であ
り、５重量％を越えると、得られる樹脂組成物の透明性
を損ない、機械的特性も低下する。The blending amount of such polypropylene glycol is 0.05 to 5% based on the entire aromatic polycarbonate resin composition.
% by weight, preferably 0.5-2% by weight. 0.0
If it is less than 5% by weight, the effect of ionizing radiation resistance will be insufficient, and if it exceeds 5% by weight, the transparency of the resulting resin composition will be impaired and the mechanical properties will also deteriorate.
ハロゲン化ビスフェノール類のアルキレンオキサイド付
加物及び／又はその多量体やポリプロピレングリコール
を芳香族ポリカーボネート樹脂に配合する方法としては
、最終成形品を成形する直前まで、任意の段階で当業者
に周知の種々の手段によって行うことが出来る。As methods for blending alkylene oxide adducts of halogenated bisphenols and/or their polymers and polypropylene glycol into aromatic polycarbonate resin, various methods well known to those skilled in the art can be used at any stage immediately before molding the final molded product. It can be done by means.
更に、本発明の樹脂組成物には、本発明の効果を損なわ
ない範囲内で、他の樹脂材料、例えば、ポリエチレンテ
レフタレートやポリブチレンテレフタレート、ポリエス
テルポリカーボネート、ボリアリレート、シクロヘキサ
ンジメタツールとテレフタル酸及びｌ又はイソフタル酸
との重縮合物またはそれとポリエチレンテレフタレート
との共重合物などを、混合して使用することが出来る。Furthermore, the resin composition of the present invention may contain other resin materials such as polyethylene terephthalate, polybutylene terephthalate, polyester polycarbonate, polyarylate, cyclohexane dimetatool, terephthalic acid, and the like, within a range that does not impair the effects of the present invention. A polycondensate of 1 or isophthalic acid or a copolymer of it and polyethylene terephthalate can be used in combination.
また、本発明の組成物には、周知の各種の添加剤、例え
ばエポキシ化合物などの加水分解防止剤、パラフィンワ
ックス、脂肪酸エステルなどの滑剤、ヒンダードフェノ
ール、リン酸エステルや亜リン酸エステルなどの酸化防
止剤、トリアジン系化合物などの耐候性改良剤、顔料、
染料などの着色剤などを含有してもよい。The composition of the present invention may also contain various well-known additives, such as hydrolysis inhibitors such as epoxy compounds, lubricants such as paraffin wax and fatty acid esters, hindered phenols, phosphoric esters, and phosphite esters. Antioxidants, weather resistance improvers such as triazine compounds, pigments,
It may also contain a coloring agent such as a dye.
本発明の芳香族ポリカーボネート樹脂組成物は、当業者
に周知の方法で製品に加工される。加工法には特に制限
はなく、例えば、射出成形、押出成形、ブロー成形、プ
レス成形などが適用されるが、特に射出成形が好ましい
。射出成形を行う場合の好ましい条件としては、樹脂温
度２８０〜３２００Ｃ１金型温度６０〜１２０°Ｃ１射
出圧力３００〜２０００ ｋｇ／ｃｍ２である。The aromatic polycarbonate resin composition of the present invention is processed into products by methods well known to those skilled in the art. There are no particular limitations on the processing method, and examples of applicable methods include injection molding, extrusion molding, blow molding, and press molding, with injection molding being particularly preferred. Preferred conditions for injection molding are: resin temperature 280-3200C, mold temperature 60-120C, injection pressure 300-2000 kg/cm2.
本発明で用いられる電離放射線については、アルファ線
、重電子線、陽子線、ベータ線、電子線、中性子線、ガ
ンマ線、及びエックス線などによるものが挙げられるが
、工業的にはガンマ線が好んで使用される。放射される
電離放射線の量は、通常は２．５ Ｍｒａｄ程度である
。The ionizing radiation used in the present invention includes alpha rays, heavy electron beams, proton beams, beta rays, electron beams, neutron beams, gamma rays, and X-rays, but gamma rays are preferably used industrially. be done. The amount of ionizing radiation emitted is typically on the order of 2.5 Mrad.
［実施例１
以下に、本発明を実施例によって具体的に説明するが、
本発明はその要旨を逸脱しない限りこれら実施例により
制限されるものではない。[Example 1] The present invention will be specifically explained below with reference to Examples.
The present invention is not limited to these Examples unless it departs from the gist thereof.
（実施例１〜５及び比較例１〜２）
粘度平均分子量２２０００のビスフェノールＡポリカー
ボネート樹脂（三菱化成（株）製、商品名ニッパレック
ス７０２２Ａ ）、に対し、ハロゲン化ビスフェノール
類のアルキレンオキサイド付加物として表−１に示す化
合物、及び、分子量４５００のポリプロピレングリコー
ル（ダウ（株）製、商品名： Ｅ−４５００）を表−１
に示す組成で配合し、樹脂温度２７０〜２９０ ’Ｃの
範囲内でスクリュー径４０ ｍｍ−のベント付押出機に
てペレット化した。このペレットを乾燥後、型締圧７５
トンの射出成形機を用い、樹脂温度２８０〜３００°Ｃ
の範囲内で５０ｍｍφＸ ３ ｍｍ厚みの円板型試験片
、及び引張試験用試験片を作成した。(Examples 1 to 5 and Comparative Examples 1 to 2) Bisphenol A polycarbonate resin with a viscosity average molecular weight of 22,000 (manufactured by Mitsubishi Kasei Corporation, trade name NIPPAREX 7022A) was treated as an alkylene oxide adduct of halogenated bisphenols. The compounds shown in Table-1 and polypropylene glycol with a molecular weight of 4500 (manufactured by Dow Corporation, trade name: E-4500) were prepared in Table-1.
The composition shown was compounded and pelletized using a vented extruder with a screw diameter of 40 mm at a resin temperature of 270 to 290'C. After drying this pellet, the mold clamping pressure was 75
Using a ton injection molding machine, the resin temperature is 280-300°C.
A disk-shaped test piece with a diameter of 50 mm and a thickness of 3 mm and a test piece for a tensile test were prepared within the range of .
こうして得られた引張試験用試験片で以下に示す方法に
より引張強度及び、引張伸を測定し、また、円板型試験
片の黄色度指数を測定し、更にその試験片を日本アイソ
トープ協会に依頼して空気中及び脱酸素雰囲気中で２．
５ Ｍｒａｄのガンマ線を照射滅菌し、２日後に再度黄
色度指数を測定した。得られた結果を表−１に示す。尚
、脱酸素雰囲気は、脱酸素剤（三菱ガス化学（株）製、
商品名エージレス）と共に密封することによって得た。Using the tensile test specimen thus obtained, the tensile strength and tensile elongation were measured using the methods shown below. Also, the yellowness index of the disc-shaped specimen was measured, and the test specimen was sent to the Japan Isotope Association. 2. in air and in a deoxidized atmosphere.
The sample was sterilized by irradiation with 5 Mrad gamma rays, and the yellowness index was measured again 2 days later. The results obtained are shown in Table-1. The deoxidizing atmosphere is a deoxidizing agent (manufactured by Mitsubishi Gas Chemical Co., Ltd.,
The product was obtained by sealing it with the product (trade name Ageless).
また、肉厚３ｍｍのアルキメデスのスパイラル型を用い
、樹脂温度３００°Ｃ１金型温度１００’Ｃ１射出圧力
１０００ ｋｇ ／ ｃｍ２にて成形し、流動長を測定
した。Further, using an Archimedean spiral mold with a wall thickness of 3 mm, molding was performed at a resin temperature of 300°C, a mold temperature of 100'C, and an injection pressure of 1000 kg/cm2, and the flow length was measured.
試験法：
引張強度、引張伸びＡＳＴＭ Ｄ６３８に準じて行った
。Test method: Tensile strength and tensile elongation were conducted according to ASTM D638.
黄色度指数 ＪＩＳ Ｋ−７１０３に準じて行っ
た。Yellowness index It was conducted according to JIS K-7103.
（亨１）ハロゲン化ビスフェノール類のエチレンオキサ
イド付加物の配合量は、芳香族ポリカーボネート樹脂組
成物全体に対する配合量（重量％）であり、（）内はハ
ロゲン原子としての含有量（重量％）を示す。(1) The amount of the ethylene oxide adduct of halogenated bisphenols is the amount (wt%) based on the entire aromatic polycarbonate resin composition, and the value in parentheses indicates the content (wt%) as a halogen atom. show.
（本２）音大化成（株）製、商品名：ファイヤガード
３６００ ；テトラブロムビスフェノールＡのエチ
レンオキサイド２モル付加物
（＊３）開成化学（株）製、商品名：ＴＢＡ−ＥＯテト
ラブロムビスフェノールＡのエチ
レンオキサイド４モル付加物
［発明の効果］
本発明の樹脂組成物は、表−２に示す通り、芳香族ポリ
カーボネート樹脂の優れた機械的特性を保持し、かつ流
動性に著しく優れ、また電離放射線による滅菌処理を受
けても、黄変が少ない。したがって、薄肉複雑な成形品
が成形可能であり、特に電離放射線滅菌を行う人工肺、
人工腎臓（例えば人工腎臓のケース）、輸血セットなど
の医療用部品の材料として有用である。(Book 2) Manufactured by Ondai Kasei Co., Ltd., product name: Fire Guard
3600; 2 moles of ethylene oxide adduct of tetrabromo bisphenol A (*3) manufactured by Kaisei Kagaku Co., Ltd., trade name: TBA-EO 4 moles of ethylene oxide adduct of tetrabromo bisphenol A [Effects of the invention] Resin of the present invention As shown in Table 2, the composition retains the excellent mechanical properties of the aromatic polycarbonate resin, has excellent fluidity, and shows little yellowing even when subjected to sterilization treatment with ionizing radiation. Therefore, thin-walled and complex molded products can be molded, especially artificial lungs for ionizing radiation sterilization.
It is useful as a material for medical parts such as artificial kidneys (for example, artificial kidney cases) and blood transfusion sets.
Claims (3)
イド付加物及び／又はその多量体を、ハロゲン原子とし
て０．１〜１０重量％含有する芳香族ポリカーボネート
樹脂組成物。(1) An aromatic polycarbonate resin composition containing 0.1 to 10% by weight of an alkylene oxide adduct of halogenated bisphenols and/or a polymer thereof as a halogen atom.
イド付加物及び／又はその多量体をハロゲン原子として
０．１〜１０重量％、及び、ポリプロピレングリコール
を０．１〜５重量％含有する芳香族ポリカーボネート樹
脂組成物。(2) An aromatic polycarbonate resin composition containing 0.1 to 10% by weight of an alkylene oxide adduct of halogenated bisphenols and/or its polymer as a halogen atom, and 0.1 to 5% by weight of polypropylene glycol. .
ポリカーボネート樹脂組成物よりなる医療用部品。(3) A medical component comprising the aromatic polycarbonate resin composition according to claim 1 or 2.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2116474A JPH0413759A (en) | 1990-05-02 | 1990-05-02 | Aromatic polycarbonate resin composition and medical goods made thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2116474A JPH0413759A (en) | 1990-05-02 | 1990-05-02 | Aromatic polycarbonate resin composition and medical goods made thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0413759A true JPH0413759A (en) | 1992-01-17 |
Family
ID=14687999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2116474A Pending JPH0413759A (en) | 1990-05-02 | 1990-05-02 | Aromatic polycarbonate resin composition and medical goods made thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0413759A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0753540A3 (en) * | 1995-07-12 | 1999-08-25 | Mitsubishi Engineering-Plastics Corporation | Polycarbonate resin composition |
-
1990
- 1990-05-02 JP JP2116474A patent/JPH0413759A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0753540A3 (en) * | 1995-07-12 | 1999-08-25 | Mitsubishi Engineering-Plastics Corporation | Polycarbonate resin composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3613484B2 (en) | Ionizing radiation resistant carbonate resin composition and medical component comprising the same | |
| EP1692204B1 (en) | Ionizing radiation stable polyarylestercarbonate compositions | |
| EP0359366B1 (en) | Medical moldings and method for their preparation | |
| EP0507547A2 (en) | Improved irradiation resistant functionally endcapped polycarbonate | |
| EP0152825B1 (en) | Use of a polymer blend for producing medical devices with improved resistance to yellowing under ionizing radiation | |
| JPH0413759A (en) | Aromatic polycarbonate resin composition and medical goods made thereof | |
| JPH02129261A (en) | Aromatic polycarbonate resin composition and medical part prepared by using same | |
| JP3038788B2 (en) | Polycarbonate resin composition and medical parts using the same | |
| JP3413297B2 (en) | Ionizing radiation-resistant carbonate resin composition and medical component comprising the same | |
| JPH0213460A (en) | Sterilization of polycarbonate resin moldings | |
| JPH047356A (en) | Aromatic polycarbonate resin composition and medical component comprising the same | |
| JPH02163156A (en) | Aromatic polycarbonate resin composition | |
| CN107922725B (en) | Ionizing radiation resistant polycarbonate resin composition and molded product comprising the same | |
| JP3642523B2 (en) | Ionizing radiation resistant carbonate resin composition and medical component comprising the same | |
| KR20170049720A (en) | Ionizing radiation resistant polycarbonate resin composition and article comprising the same | |
| JPH05179127A (en) | Phthalic acid derivative having brominated nucleus for stabilizing thermoplastic polycarbonate against the action of gamma-ray | |
| JP3330793B2 (en) | Polycarbonate resin composition | |
| JP2016113532A (en) | Dialyzer | |
| CN105602223B (en) | Ionizing radiation resistant polycarbonate resin composition and article comprising the same | |
| JPH062156B2 (en) | Anti-ionizing radiation material | |
| JPH0538361A (en) | Therapeutic part made of ionizing radiation resistant material | |
| JPH01270869A (en) | Method of sterilizing polycarbonate resin molding | |
| JPH08225734A (en) | Gamma-ray-resistant polycarbonate resin composition | |
| JPH09100402A (en) | Polycarbonate resin composition | |
| JPS63314269A (en) | Polycarbonate resin composition |